Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Zuckerman

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
JACC. Heart Failure|December 3, 2016
The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure DevicesMatthew Hillebrenner, Bram Zuckerman, Mona Fiuzat, et al.
Heart Rhythm|September 28, 2010
Interventional cardiology live case presentations regulatory considerationsAndrew Farb, Sheila A Brown, Deborah A Wolf, et al.
The Annals of Thoracic Surgery|August 25, 2006
FDA perspective on clinical trial design for cardiovascular devicesEric Chen, Wolf Sapirstein, Chul Ahn, et al.
Journal of the American College of Cardiology|October 2, 2010
Interventional cardiology live case presentations: regulatory considerationsAndrew Farb, Sheila A Brown, Deborah A Wolf, et al.
Journal of the American College of Cardiology|January 14, 2022
The Heart Valve Collaboratory: A Disruptive Model in the Management of Valvular Heart DiseaseMichael J Mack, Martin B Leon, Changfu Wu, et al.
Journal of Biopharmaceutical Statistics|August 20, 2016
Utilizing national and international registries to enhance pre-market medical device regulatory evaluationLilly Q Yue, Gregory Campbell, Nelson Lu, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 30, 2016
New technology in electrophysiology: FDA process and perspectiveKimberly A Selzman, Mark Fellman, Andrew Farb, et al.
American Journal of Therapeutics|June 7, 2012
An analysis of implantable cardiac device reliability. The case for improved postmarketing risk assessment and surveillanceWarren Laskey, Khaled Awad, Jeremy Lum, et al.
JACC. Heart Failure|March 4, 2017
JACC: Heart Failure Series: FDA in the 21st Century: Focus on Nutrition and Heart Failure PreventionMona Fiuzat, Susan T Mayne, Matt Hillebrenner, et al.
JACC. Heart Failure|December 31, 2016
The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug DevelopmentNorman Stockbridge, Kristen Miller, Shashi Amur, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
JACC. Heart Failure|December 3, 2016
The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure DevicesMatthew Hillebrenner, Bram Zuckerman, Mona Fiuzat, et al.
Heart Rhythm|September 28, 2010
Interventional cardiology live case presentations regulatory considerationsAndrew Farb, Sheila A Brown, Deborah A Wolf, et al.
The Annals of Thoracic Surgery|August 25, 2006
FDA perspective on clinical trial design for cardiovascular devicesEric Chen, Wolf Sapirstein, Chul Ahn, et al.
Journal of the American College of Cardiology|October 2, 2010
Interventional cardiology live case presentations: regulatory considerationsAndrew Farb, Sheila A Brown, Deborah A Wolf, et al.
Journal of the American College of Cardiology|January 14, 2022
The Heart Valve Collaboratory: A Disruptive Model in the Management of Valvular Heart DiseaseMichael J Mack, Martin B Leon, Changfu Wu, et al.
Journal of Biopharmaceutical Statistics|August 20, 2016
Utilizing national and international registries to enhance pre-market medical device regulatory evaluationLilly Q Yue, Gregory Campbell, Nelson Lu, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 30, 2016
New technology in electrophysiology: FDA process and perspectiveKimberly A Selzman, Mark Fellman, Andrew Farb, et al.
American Journal of Therapeutics|June 7, 2012
An analysis of implantable cardiac device reliability. The case for improved postmarketing risk assessment and surveillanceWarren Laskey, Khaled Awad, Jeremy Lum, et al.
JACC. Heart Failure|March 4, 2017
JACC: Heart Failure Series: FDA in the 21st Century: Focus on Nutrition and Heart Failure PreventionMona Fiuzat, Susan T Mayne, Matt Hillebrenner, et al.
JACC. Heart Failure|December 31, 2016
The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug DevelopmentNorman Stockbridge, Kristen Miller, Shashi Amur, et al.
Pageof 4